Evidence map›Paper›PMID 42848776›Full record

ArticlePloS one2026

Systematic review and network meta-analysis of interventions for adults with simple obesity: Study protocol.

Lingyao Sun, Lizhen Xu, Dachuang Zhou, Jun Wang, Xuan Yin, Wentao Ye, Lei Tian

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lingyao SunCentre for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, China.
Lizhen XuDepartment of Endocrinology, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
Dachuang ZhouCentre for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, China.
Jun WangMolecular Imaging Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia, Medica, Chinese Academy of Sciences, Shanghai, China.
Xuan YinFaculty of Health Sciences, University of Macau, Macau, China.
Wentao YeCentre for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, China.
Lei TianCentre for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, China.ORCID https://orcid.org/0000-0002-5364-2061

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity has become a major global public health challenge, and its rising prevalence contributes to substantial health and economic burdens. Existing systematic reviews are largely confined to a single intervention category or to mixed populations, which limits targeted recommendations for adults in whom obesity itself, rather than an established metabolic comorbidity, is the principal clinical concern. This protocol describes a systematic review and network meta-analysis comparing dietary, physical activity, behavioural and pharmacological interventions in adults with simple obesity, pragmatically defined as trial populations in which obesity itself is the primary inclusion criterion. We will search PubMed, Embase and the Cochrane Library from inception to the search date for randomised controlled trials. Two reviewers will independently screen records, extract data and assess risk of bias using the Cochrane Risk of Bias 2 tool. The principal primary outcome will be percentage change in body weight at the end of an intervention period of at least 24 weeks. Key secondary outcomes will include the proportion of participants achieving at least 5% weight loss, separate measures of central obesity, and health-related quality of life. Pairwise and network meta-analyses will be conducted under a frequentist random-effects framework, and small-study effects will be examined with funnel plots and regression-based tests. Subgroup analyses and meta-regression will explore prespecified effect modifiers, and the credibility of important subgroup findings will be judged with the ICEMAN instrument. Certainty of evidence will be assessed using the GRADE framework. Depending on the quality, consistency and certainty of the available evidence, the findings may inform clinical decision-making, future guideline development and research priorities. This review is registered with PROSPERO (CRD420251236477).

Indexed as

ObesityAdultExerciseHumansNetwork Meta-Analysis as TopicQuality of LifeResearch DesignSystematic Reviews as TopicWeight Loss

Identifiers

PMID42848776
PMCPMC13648986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.